CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 124 filers reported holding CARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,365,394 | -40.5% | 2,598,449 | +0.2% | 0.00% | – |
| Q2 2023 | $7,340,958 | -52.1% | 2,593,978 | -16.9% | 0.00% | – |
| Q1 2023 | $15,333,075 | -54.0% | 3,122,826 | +0.7% | 0.00% | -100.0% |
| Q4 2022 | $33,312,516 | +7.6% | 3,101,724 | -6.2% | 0.00% | 0.0% |
| Q3 2022 | $30,962,000 | +3.8% | 3,307,851 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $29,834,000 | -24.3% | 3,267,654 | +0.7% | 0.00% | 0.0% |
| Q1 2022 | $39,419,000 | +6.7% | 3,244,377 | +7.0% | 0.00% | 0.0% |
| Q4 2021 | $36,940,000 | -20.6% | 3,032,762 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $46,518,000 | +18.8% | 3,010,880 | +9.7% | 0.00% | 0.0% |
| Q2 2021 | $39,172,000 | -19.9% | 2,745,097 | +21.8% | 0.00% | 0.0% |
| Q1 2021 | $48,919,000 | +43.1% | 2,253,247 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $34,176,000 | +19.9% | 2,258,763 | +0.8% | 0.00% | 0.0% |
| Q3 2020 | $28,501,000 | -26.1% | 2,239,799 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $38,585,000 | +28.3% | 2,256,468 | -0.9% | 0.00% | 0.0% |
| Q1 2020 | $30,075,000 | -14.0% | 2,276,697 | +4.8% | 0.00% | 0.0% |
| Q4 2019 | $34,984,000 | -11.9% | 2,171,545 | -0.1% | 0.00% | 0.0% |
| Q3 2019 | $39,716,000 | +3.8% | 2,172,686 | +22.1% | 0.00% | 0.0% |
| Q2 2019 | $38,258,000 | +10.4% | 1,779,452 | +0.8% | 0.00% | 0.0% |
| Q1 2019 | $34,649,000 | +62.0% | 1,766,035 | +7.4% | 0.00% | 0.0% |
| Q4 2018 | $21,383,000 | -42.4% | 1,644,810 | +6.0% | 0.00% | 0.0% |
| Q3 2018 | $37,155,000 | +55.7% | 1,551,344 | +24.5% | 0.00% | 0.0% |
| Q2 2018 | $23,867,000 | +56.6% | 1,246,324 | +1.3% | 0.00% | 0.0% |
| Q1 2018 | $15,238,000 | +2.3% | 1,230,916 | +1.1% | 0.00% | 0.0% |
| Q4 2017 | $14,901,000 | -7.9% | 1,217,361 | +3.0% | 0.00% | 0.0% |
| Q3 2017 | $16,184,000 | -5.1% | 1,182,217 | +6.7% | 0.00% | 0.0% |
| Q2 2017 | $17,050,000 | -1.7% | 1,107,874 | +17.4% | 0.00% | 0.0% |
| Q1 2017 | $17,353,000 | +137.5% | 943,627 | +20.0% | 0.00% | – |
| Q4 2016 | $7,308,000 | +21.0% | 786,669 | +8.7% | 0.00% | – |
| Q3 2016 | $6,040,000 | +87.3% | 723,449 | +7.9% | 0.00% | – |
| Q2 2016 | $3,225,000 | -24.6% | 670,465 | -2.5% | 0.00% | – |
| Q1 2016 | $4,276,000 | -61.4% | 687,439 | +4.6% | 0.00% | -100.0% |
| Q4 2015 | $11,077,000 | -94.0% | 657,030 | -88.2% | 0.00% | -85.7% |
| Q3 2015 | $183,563,000 | +5193.1% | 5,590,962 | +1858.9% | 0.01% | – |
| Q2 2015 | $3,468,000 | +48.8% | 285,407 | +23.1% | 0.00% | – |
| Q1 2015 | $2,330,000 | +33.5% | 231,778 | +32.4% | 0.00% | – |
| Q4 2014 | $1,745,000 | +18.6% | 175,102 | -0.1% | 0.00% | – |
| Q3 2014 | $1,471,000 | -64.3% | 175,299 | -27.5% | 0.00% | – |
| Q2 2014 | $4,116,000 | +130.3% | 241,867 | +151.9% | 0.00% | – |
| Q1 2014 | $1,787,000 | – | 96,036 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |